Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 2, Issue 1
  5. Article
Volume 2, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format pdf download PDF
side by side viewer icon HTML

Abstract

Polycystic ovary syndrome (PCOS) is a significant gynecological disorder that commonly affects women of reproductive age. Disturbances in the production and metabolism of androgens and estrogens mark the condition. Due to the rising occurrence of PCOS and its related physical and psychological issues, along with the role of sex hormone fluctuations in its development, the use of marketed drugs is effective in treating PCOS but is accompanied by negative consequences. Consequently, a significant number of individuals with PCOS are opting for natural remedies due to the positive therapeutic effects associated with natural medications and the constraints of allopathic treatments. This review aims to assess the impact of different herbs on alterations in sex hormone levels in the bloodstream and ovarian tissue. By conducting a comprehensive literature search utilizing databases such as PubMed, Google Scholar, and Crossref, we have gathered and analyzed pertinent information regarding the efficacy of herbal remedies in combating PCOS. Based on the available evidence, herbs consisting of phytoestrogens can potentially reduce insulin resistance, hyperandrogenism, and ovarian weight while facilitating ovulation. This review explores the importance of herbal remedies in addressing PCOS, elucidates their mechanisms of action, and examines the therapeutic uses of specific herbal medications to treat PCOS. Human studies on medicinal herbs for managing Polycystic Ovary Syndrome (PCOS) need extended durations for a comprehensive evaluation of both safety and efficacy, emphasizing the necessity for more long-term research. It is anticipated that this comprehensive review will serve as a valuable resource for researchers studying the effect of herbs on PCOS, providing them with valuable insights and information.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X272638240213105938
2024-02-26
2025-01-31

  • From This Site

    /content/journals/cis/10.2174/012210299X272638240213105938
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/2/1/CIS-2-E2210299X272638.html?itemId=/content/journals/cis/10.2174/012210299X272638240213105938&mimeType=html&fmt=ahah

References

  1. NdefoU.A. EatonA. GreenM.R. Polycystic ovary syndrome: A review of treatment options with a focus on pharmacological approaches.P&T201338633635523946629
     [Google Scholar]
  2. DeUgarteC.M. BartolucciA.A. AzzizR. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.Fertil. Steril.20058351454146010.1016/j.fertnstert.2004.11.07015866584
     [Google Scholar]
  3. SartorB.M. DickeyR.P. Polycystic ovarian syndrome and the metabolic syndrome.Am. J. Med. Sci.2005330633634210.1097/00000441‑200512000‑0001216355019
     [Google Scholar]
  4. AzzizR. WoodsK.S. ReynaR. KeyT.J. KnochenhauerE.S. YildizB.O. The prevalence and features of the polycystic ovary syndrome in an unselected population.J. Clin. Endocrinol. Metab.20048962745274910.1210/jc.2003‑03204615181052
     [Google Scholar]
  5. KnochenhauerE.S. KeyT.J. Kahsar-MillerM. WaggonerW. BootsL.R. AzzizR. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study.J. Clin. Endocrinol. Metab.19988393078308210.1210/jc.83.9.30789745406
     [Google Scholar]
  6. NaessenT. KushnirM.M. ChaikaA. NosenkoJ. MogilevkinaI. RockwoodA.L. CarlstromK. BergquistJ. KirilovasD. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry.Fertil. Steril.20109462228223310.1016/j.fertnstert.2009.12.08120171618
     [Google Scholar]
  7. BrennerR.M. SlaydenO.D. CritchleyH.O. Anti-proliferative effects of progesterone antagonists in the primate endometrium: A potential role for the androgen receptor.Reproduction2002124216717210.1530/rep.0.124016712141929
     [Google Scholar]
  8. RosenfieldR.L. EhrmannD.A. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited.Endocr. Rev.201637546752010.1210/er.2015‑110427459230
     [Google Scholar]
  9. MobeenH. AfzalN. KashifM. Polycystic ovary syndrome may be an autoimmune disorder.Scientifica201620161710.1155/2016/407173527274883
     [Google Scholar]
  10. NormanR.J. DewaillyD. LegroR.S. HickeyT.E. Polycystic ovary syndrome.Lancet2007370958868569710.1016/S0140‑6736(07)61345‑217720020
     [Google Scholar]
  11. ToscaniM.K. MarioF.M. Radavelli-BagatiniS. SpritzerP.M. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.Nutr. Res.20113129710310.1016/j.nutres.2011.01.00921419313
     [Google Scholar]
  12. MarxT.L. MehtaA.E. Polycystic ovary syndrome: Pathogenesis and treatment over the short and long term.Cleve. Clin. J. Med.20037013133, 36-41, 4510.3949/ccjm.70.1.3112549723
     [Google Scholar]
  13. JelodarG. AskariK. Effect of Vitex agnus-castus fruits hydroalcoholic extract on sex hormones in rat with induced polycystic ovary syndrome (PCOS).Physiol. Pharmacol.20121616269
     [Google Scholar]
  14. KhaniB. FerdousM. ElahehK. AzadehE. Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome.J Res Med Sci2011163297302
     [Google Scholar]
  15. BeckV. RohrU. JungbauerA. Phytoestrogens derived from red clover: An alternative to estrogen replacement therapy?J. Steroid Biochem. Mol. Biol.200594549951810.1016/j.jsbmb.2004.12.03815876415
     [Google Scholar]
  16. Viuda-MartosM. Fernández-LópezJ. Pérez-ÁlvarezJ.A. Pomegranate and its many functional components as related to human health: A review.Compr. Rev. Food Sci. Food Saf.20109663565410.1111/j.1541‑4337.2010.00131.x33467822
     [Google Scholar]
  17. XitaN. GeorgiouI. TsatsoulisA. The genetic basis of polycystic ovary syndrome.Eur. J. Endocrinol.2002147671772510.1530/eje.0.147071712457445
     [Google Scholar]
  18. Diamanti-KandarakisE. KandarakisH. LegroR.S. The role of genes and environment in the etiology of PCOS.Endocr. J.2006301192610.1385/ENDO:30:1:1917185788
     [Google Scholar]
  19. KwonC.Y. ChoI.H. ParkK.S. Therapeutic effects and mechanisms of herbal medicines for treating polycystic ovary syndrome: A review.Front. Pharmacol.202011119210.3389/fphar.2020.0119232903374
     [Google Scholar]
  20. GoswamiP.K. KhaleA. OgaleS. Natural remedies for polycystic ovarian syndrome (PCOS): A review.Int. J. Pharm. Phytopharmacological Res.201216396402
     [Google Scholar]
  21. KwonC.Y. LeeB. ParkK.S. Oriental herbal medicine and moxibustion for polycystic ovary syndrome.Medicine20189743e1294210.1097/MD.000000000001294230412108
     [Google Scholar]
  22. DupontJ. ScaramuzziR.J. Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle.Biochem. J.2016473111483150110.1042/BCJ2016012427234585
     [Google Scholar]
  23. ToulisK.A. GoulisD.G. FarmakiotisD. GeorgopoulosN.A. KatsikisI. TarlatzisB.C. PapadimasI. PanidisD. Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis.Hum. Reprod. Update200915329730710.1093/humupd/dmp00619261627
     [Google Scholar]
  24. HobergE. OrjalaJ. MeierB. SticherO. Diterpenoids from the fruits of Vitex agnus-castus.Phytochemistry19995281555155810.1016/S0031‑9422(99)00181‑8
     [Google Scholar]
  25. BalenA. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.Best Pract. Res. Clin. Obstet. Gynaecol.200418568570610.1016/j.bpobgyn.2004.05.00415380141
     [Google Scholar]
  26. SidraS. TariqM.H. FarrukhM.J. MohsinM. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome.PLoS One20191410e022332910.1371/journal.pone.022332931603907
     [Google Scholar]
  27. ShannonM. WangY. Polycystic ovary syndrome: A common but often unrecognized condition.J. Midwifery Womens Health201257322123010.1111/j.1542‑2011.2012.00161.x22594862
     [Google Scholar]
  28. LeeY.A. ChoE.J. YokozawaT. Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence.Biol. Pharm. Bull.20083161265126910.1248/bpb.31.126518520066
     [Google Scholar]
  29. PatelS. PatelS. Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity.Virusdisease201627324225010.1007/s13337‑016‑0334‑828466035
     [Google Scholar]
  30. RohE.Y. YoonJ.H. SongE.Y. KimJ.J. HwangK.R. SeoS.H. ShinS. Single nucleotide polymorphisms in the TGF-β1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: A study in Korean women.J. Assist. Reprod. Genet.201734113914710.1007/s10815‑016‑0824‑z27796807
     [Google Scholar]
  31. WuJ.B. ZhaiJ.F. YangJ. Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk.Genet. Mol. Res.201615(4).10.4238/gmr1504857028081274
     [Google Scholar]
  32. DasguptaS. SirishaP.V.S. NeelaveniK. AnuradhaK. SudhakarG. ReddyB.M. Role of luteinizing hormone β-subunit gene variants among South Indian women with polycystic ovary syndrome.Gene20124941515610.1016/j.gene.2011.11.05422209983
     [Google Scholar]
  33. SaidunnisaB. Prevalence of polycystic ovarian syndrome among students of rak medical and health sciences University United Arab Emirates.Int. J. Med. Pharm. Sci20166109118
     [Google Scholar]
  34. PelluriR. SrikanthK. ParitalaH. RaviV. Mukharjee KammaS.P. PidugurallaK.D. VenkateswarluU. SubrahmanyamJ. BannaravuriK. ThungaT. VemparalaR. DoddapaneniS. AvulamandaN. SivaniV. PuttaguntaS. The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients.Clin. Epidemiol. Glob. Health20211210091010.1016/j.cegh.2021.100910
     [Google Scholar]
  35. O’ReillyM. GathercoleL. CapperF. ArltW. TomlinsonJ. Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome.Lancet2015385S1S1610.1016/S0140‑6736(15)60331‑226312838
     [Google Scholar]
  36. AminiL. TehranianN. MovahedinM. Ramezani TehraniF. ZiaeeS. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.Iran. J. Reprod. Med.20151311825653669
     [Google Scholar]
  37. ArentzS. AbbottJ.A. SmithC.A. BensoussanA. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.BMC Complement. Altern. Med.201414151110.1186/1472‑6882‑14‑51125524718
     [Google Scholar]
  38. KhanageS.G. SubhashT.Y. BhaiyyasahebI.R. Herbal drugs for the treatment of polycystic ovary syndrome (PCOS) and its complications.Pharm. Res.20192151331823112
     [Google Scholar]
  39. DunneN. The natural diet solution for PCOS and Infertility: How to manage polycystic ovary syndrome naturally.Health Solutions Press2006
     [Google Scholar]
  40. AzzizR. CarminaE. DewaillyD. Diamanti-KandarakisE. Escobar-MorrealeH.F. FutterweitW. JanssenO.E. LegroR.S. NormanR.J. TaylorA.E. WitchelS.F. Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline.J. Clin. Endocrinol. Metab.200691114237424510.1210/jc.2006‑017816940456
     [Google Scholar]
  41. MarchW.A. MooreV.M. WillsonK.J. PhillipsD.I.W. NormanR.J. DaviesM.J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum. Reprod.201025254455110.1093/humrep/dep39919910321
     [Google Scholar]
  42. BozdagG. MumusogluS. ZenginD. KarabulutE. YildizB.O. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis.Hum. Reprod.201631122841285510.1093/humrep/dew21827664216
     [Google Scholar]
  43. BoyleJ. TeedeH.J. Polycystic ovary syndrome - an update.Aust. Fam. Physician2012411075275623210095
     [Google Scholar]
  44. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil. Steril.2004811192510.1016/j.fertnstert.2003.10.00414711538
     [Google Scholar]
  45. TeedeH.J. MissoM.L. CostelloM.F. DokrasA. LavenJ. MoranL. PiltonenT. NormanR.J. AndersenM. AzzizR. BalenA. BayeE. BoyleJ. BrennanL. BroekmansF. DabadghaoP. DevotoL. DewaillyD. DownesL. FauserB. FranksS. GaradR.M. Gibson-HelmM. HarrisonC. HartR. HawkesR. HirschbergA. HoegerK. HohmannF. HutchisonS. JohamA. JohnsonL. JordanC. KulkarniJ. LegroR.S. LiR. LujanM. MalhotraJ. MansfieldD. MarshK. McAllisterV. MocanuE. MolB.W. NgE. OberfieldS. OtteyS. PeñaA. QiaoJ. RedmanL. RodgersR. RombautsL. RomualdiD. ShahD. SpeightJ. SpritzerP.M. Stener-VictorinE. SteptoN. TapanainenJ.S. TassoneE.C. ThangaratinamS. ThondanM. TzengC-R. van der SpuyZ. VankyE. VogiatziM. WanA. WijeyaratneC. WitchelS. WoolcockJ. YildizB.O. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†.Hum. Reprod.20183391602161810.1093/humrep/dey25630052961
     [Google Scholar]
  46. Escobar-MorrealeH.F. Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment.Nat. Rev. Endocrinol.201814527028410.1038/nrendo.2018.2429569621
     [Google Scholar]
  47. YildizB.O. Diagnosis of hyperandrogenism: Clinical criteria.Best Pract. Res. Clin. Endocrinol. Metab.200620216717610.1016/j.beem.2006.02.00416772149
     [Google Scholar]
  48. Mitrašinović-BrulićM. BuljanM. SuljevićD. Association of LH/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome.Middle East Fertil. Soc. J.20212611933437145
     [Google Scholar]
  49. BarbosaG. de SáL.B.P.C. RochaD.R.T.W. ArbexA.K. Polycystic ovary syndrome (PCOS) and fertility.Open J. Endocr. Metab. Dis.201661586510.4236/ojemd.2016.61008
     [Google Scholar]
  50. TerryN. RyanM. Polycystic Ovary Syndrome (PCOS) 2012.Bethesda, MdNational Institutes of Health Library2021
     [Google Scholar]
  51. NicolaidesN.C. MatheouA. VlachouF. NeocleousV. SkordisN. Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management.Acta Biomed.2020913e202008532921781
     [Google Scholar]
  52. TeedeH. MarieL.M. MichaelF.C. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.Fertil Steril20181103364379
     [Google Scholar]
  53. WangR. MolB.W.J. The Rotterdam criteria for polycystic ovary syndrome: Evidence-based criteria?Hum. Reprod.201732226126410.1093/humrep/dew28728119448
     [Google Scholar]
  54. BarryJ.A. AziziaM.M. HardimanP.J. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis.Hum. Reprod. Update201420574875810.1093/humupd/dmu01224688118
     [Google Scholar]
  55. AzzizR. MarinC. HoqL. BadamgaravE. SongP. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.J. Clin. Endocrinol. Metab.20059084650465810.1210/jc.2005‑062815944216
     [Google Scholar]
  56. AzzizR. CarminaE. DewaillyD. Diamanti-KandarakisE. Escobar-MorrealeH.F. FutterweitW. JanssenO.E. LegroR.S. NormanR.J. TaylorA.E. WitchelS.F. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.Fertil. Steril.200991245648810.1016/j.fertnstert.2008.06.03518950759
     [Google Scholar]
  57. KenigsbergL.E. Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.Fertil Steril2015104513029.e1-410.1016/j.fertnstert.2015.08.002
     [Google Scholar]
  58. TeedeH.J. MissoM.L. BoyleJ.A. GaradR.M. McAllisterV. DownesL. Gibson-HelmM. HartR.J. RombautsL. MoranL. DokrasA. LavenJ. PiltonenT. RodgersR.J. ThondanM. CostelloM.F. NormanR.J. BayeE. BrennanL. HarrisonC. HutchisonS. JohamA. JohnsonL. JordanC. KulkarniJ. MansfieldD. MarshK. MolB.W. PeñaA. RodgersR. SpeightJ. SteptoN. TassoneE.C. WanA. WoolcockJ. Translation and implementation of the Australian-led PCOS guideline: Clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.Med. J. Aust.2018209S7S3S810.5694/mja18.0065630453865
     [Google Scholar]
  59. MoranL.J. TassoneE.C. BoyleJ. BrennanL. HarrisonC.L. HirschbergA.L. LimS. MarshK. MissoM.L. RedmanL. ThondanM. WijeyaratneC. GaradR. SteptoN.K. TeedeH.J. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management.Obes. Rev.20202110e1304610.1111/obr.1304632452622
     [Google Scholar]
  60. KoustaE. TolisG. FranksS. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences.Hormones20054313314710.14310/horm.2002.1115116613823
     [Google Scholar]
  61. SaadiaZ. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs. Non-obese women.Med. Arh.202074428929310.5455/medarh.2020.74.289‑29333041447
     [Google Scholar]
  62. ChoudharyK. An updated overview of polycystic ovary syndrome.Int. J. Biol. Sci.201973113
     [Google Scholar]
  63. LegroR.S. Polycystic ovary syndrome: Current and future treatment paradigms.Am. J. Obstet. Gynecol.19981796S101S10810.1016/S0002‑9378(98)70240‑69855616
     [Google Scholar]
  64. GuzickD.S. Polycystic ovary syndrome.Obstet. Gynecol.2004103118119310.1097/01.AOG.0000104485.44999.C614704263
     [Google Scholar]
  65. FarquharC. BrownJ. MarjoribanksJ. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst Rev2012136CD00112210.1002/14651858.CD001122.pub4
     [Google Scholar]
  66. ZimmermanL.D. SettonR. PereiraN. RosenwaksZ. Contemporary management of polycystic ovarian syndrome.Clin. Obstet. Gynecol.201962227128110.1097/GRF.000000000000044930994482
     [Google Scholar]
  67. CarrB. BradshawK. Disorders of the ovary and female reproductive tract.Harrison's Princ. Inter. Medicine 20051622198
     [Google Scholar]
  68. StankiewiczM. NormanR. Diagnosis and management of polycystic ovary syndrome: A practical guide.Drugs200666790391210.2165/00003495‑200666070‑0000216740005
     [Google Scholar]
  69. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupConsensus on infertility treatment related to polycystic ovary syndrome.Fertil. Steril.200889350552210.1016/j.fertnstert.2007.09.04118243179
     [Google Scholar]
  70. BrownJ. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation.Cochrane Database Syst. Rev.20051CD00224910.1002/14651858.CD002249.pub3
     [Google Scholar]
  71. FauserB.C.J.M. TarlatzisB.C. RebarR.W. LegroR.S. BalenA.H. LoboR. CarminaH. ChangR.J. YildizB.O. LavenJ.S.E. BoivinJ. PetragliaF. WijeyeratneC.N. NormanR.J. DunaifA. FranksS. WildR.A. DumesicD. BarnhartK. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS).Hum. Reprod.2012271142410.1093/humrep/der39622147920
     [Google Scholar]
  72. MessinisI.E. Ovulation induction: A mini review.Hum. Reprod.200520102688269710.1093/humrep/dei12816006478
     [Google Scholar]
  73. PolsonD.W. KiddyD.S. MasonH.D. FranksS. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.Fertil. Steril.1989511303410.1016/S0015‑0282(16)60423‑52491994
     [Google Scholar]
  74. KoustaE. WhiteD.M. FranksS. Modern use of clomiphene citrate in induction of ovulation.Hum. Reprod. Update19973435936510.1093/humupd/3.4.3599459281
     [Google Scholar]
  75. TangT. GlanvilleJ. HaydenC.J. WhiteD. BarthJ.H. BalenA.H. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.Hum. Reprod.2006211808910.1093/humrep/dei31116199429
     [Google Scholar]
  76. WilliamsonE. Synergy and other interactions in phytomedicines.Phytomedicine20018540140910.1078/0944‑7113‑0006011695885
     [Google Scholar]
  77. PinnG. PallettL. Herbal medicine in pregnancy.Complement. Ther. Nurs. Midwifery200282778010.1054/ctnm.2001.062012188161
     [Google Scholar]
  78. LeeY. YangH. LeeS. KwonS. HongE.J. LeeH. Welsh onion root (Allium fistulosum) restores ovarian functions from letrozole induced-polycystic ovary syndrome.Nutrients20181010143010.3390/nu1010143030287740
     [Google Scholar]
  79. RadhaM. LaxmipriyaN. Efficacy of non polar extract (NPE) of Aloe barbadensis mill. in polycystic ovarian syndrome (PCOS) rodent model-an” in vivo” study.Int. J. Pharm. Sci. Res.20167124933
     [Google Scholar]
  80. ZhouJ. An atractylodes macrocephala koidz extract alleviates hyperandrogenism of polycystic ovarian syndrome.Int. J. Clin. Exp. Med.20169227582767
     [Google Scholar]
  81. SoumyaV. MuzibY.I. VenkateshP. A novel method of extraction of bamboo seed oil (Bambusa bambos Druce) and its promising effect on metabolic symptoms of experimentally induced polycystic ovarian disease.Indian J. Pharmacol.201648216216710.4103/0253‑7613.17883327127318
     [Google Scholar]
  82. TahvilianR. The therapeutic effect of methanolic extract Bryonia dioica Jacq. in a female rat model of polycystic ovary syndrome.J. Rep. Pharm. Sci.202211179
     [Google Scholar]
  83. GhafurniyanH. AzarniaM. NabiuniM. KarimzadehL. The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat. Iranian journal of pharmaceutical research.Iran. J. Pharm. Res.20151441215123326664389
     [Google Scholar]
  84. ShendeA. JoshiS. KoliP.G. Evaluation of the effects of caesalpinia crista on letrozole-induced models of polycystic ovarian syndrome.Cureus2023151e3421510.7759/cureus.3421536843780
     [Google Scholar]
  85. FaridehZ.Z. BagherM. AshrafA. AkramA. KazemM. Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome.J. Reprod. Infertil.201011316917423926485
     [Google Scholar]
  86. DouL. ZhengY. LiL. GuiX. ChenY. YuM. GuoY. The effect of cinnamon on polycystic ovary syndrome in a mouse model.Reprod. Biol. Endocrinol.20181619910.1186/s12958‑018‑0418‑y30340496
     [Google Scholar]
  87. SoumyaV. MuzibY.I. VenkateshP. HariprasathK. GC-MS analysis of Cocus nucifera flower extract and its effects on heterogeneous symptoms of polycystic ovarian disease in female Wistar rats.Chin. J. Nat. Med.201412967768410.1016/S1875‑5364(14)60103‑525263979
     [Google Scholar]
  88. DemirelM.A. IlhanM. SuntarI. KelesH. Kupeli AkkolE. Activity of Corylus avellana seed oil in letrozole-induced polycystic ovary syndrome model in rats.Rev. Bras. Farmacogn.2016261838810.1016/j.bjp.2015.09.009
     [Google Scholar]
  89. YounasA. LiaqatH. ArhamS. Effects of fagonia indica on letrozole-induced polycystic ovarian syndrome (PCOS) in young adult female rats.Evid. Based Complement. Alternat. Med.202220221397060
     [Google Scholar]
  90. KarampoorP. The effect of hydroalcoholic extract of fennel (foeniculum vulgare) seed on serum levels of sexual hormones in female wistar rats with polycystic ovarian syndrome (PCOS).J. Arak Univ. Med. Sci.20141757078
     [Google Scholar]
  91. RajanR.K. MS.S.K. BalajiB. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.Pharm. Biol.201755124225110.1080/13880209.2016.125842527927075
     [Google Scholar]
  92. AhmadiA. MostafaviM. Study on the effects of licorice root hydroalcoholiclicorice extract on mice uterus histological structure and level of testosterone improvement with hyperandrogenism following experimental polycystic ovary syndrome.J Res. Med. Sci.2015267571581
     [Google Scholar]
  93. AlizadehF. Effect of fruit heracleum persicum extract on changes in serum levels of sex hormones in rats with polcystic ovary syndrome (PCOS).Armaghane danesh20152013142
     [Google Scholar]
  94. ManneråsL. FazlianaM. Wan NazaimoonW.M. LönnM. GuH.F. ÖstensonC.G. Stener-VictorinE. Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome.J. Ethnopharmacol.2010127234635110.1016/j.jep.2009.10.03219883744
     [Google Scholar]
  95. MokhtariM. EbrahimpoorM.R. HarfshenoS. The effects of alcoholic extract of Marrubum vulgare on hormonal parameters in female rat model of polycystic ovarian syndrome.Med. Sci. J. Islam. Azad Univ.20142427480
     [Google Scholar]
  96. HussainL. Therapeutic investigation of standardized aqueous methanolic extract of bitter melon (Momordica charantia L.) for its potential against polycystic ovarian syndrome in experimental animals' model: In vitro and in vivo studies.Evid. Based. Complement. Alternat. Med.202220225143653
     [Google Scholar]
  97. AmouraM. Potential effects of Mentha piperita (peppermint) on Letrozole-induced polycystic ovarian syndrome in female albino rat.Int. J.2015310211226
     [Google Scholar]
  98. BhuvaneshwariS. PoornimaR. AveralH. Management of obesity in polycystic ovary syndrome induced albino rats with Pergularia daemia.Int. J. Appl. Res.20151779783
     [Google Scholar]
  99. PokaleS.B. JadhavG. Piper longum (Linn.) restores ovarian function in Letrozole induced PCOS in Rats: Comparison with Metformin and Clomiphene citrate.Res. J. Pharm. Technol.202114105190519610.52711/10.52711/0974‑360X.2021.00903
     [Google Scholar]
  100. HosseinK. LeilaK. EbrahimT. NazaninS. FarzadP. ElhamR. MohammadP. ZahraH. The effect of pomegranate juice extract on hormonal changes of female Wistar rats caused by polycystic ovarian syndrome.Biomed. Pharmacol. J.20158297197710.13005/bpj/849
     [Google Scholar]
  101. NdeingangE.C. PatrickB.D.D. PierreW. Phyllanthus muellerianus (Euphorbiaceae) restores ovarian functions in letrozole-induced polycystic ovarian syndrome in rats.Evid. Based. Complement. Alternat. Med.201920192965821
     [Google Scholar]
  102. BardeiK. The effects of hydro-alcoholic extract of raspberry fruit on ovarian follicles and serum parameters in poly cystic ovary syndrome-induced rat.Armaghan J20151911955968
     [Google Scholar]
  103. AlizadehF. RamezaniM. PiravarZ. Effects of Stachys sylvatica hydroalcoholic extract on the ovary and hypophysis-gonadal axis in a rat with polycystic ovary syndrome.Middle East Fertil. Soc. J.202025117
     [Google Scholar]
  104. KhosrowpourZ. FahimiS. JafariF. TansazM. SahranavardS. FaiziM. Beneficial effects of Teucrium polium hydroalcoholic extract on letrozole-induced polycystic ovary syndrome in rat model.Obstet. Gynecol. Sci.202366210711736575561
     [Google Scholar]
  105. AbbasianZ. Jafari BarmakM. BarazeshF. GhavamizadehM. MirzaeiA. Therapeutic efficacy of Trifolium pratense L. on letrozole induced polycystic ovary syndrome in rats.Plant Sci. Today20207350150710.14719/pst.2020.7.3.845
     [Google Scholar]
  106. KakadiaN. PatelP. DeshpandeS. ShahG. Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome.J. Tradit. Complement. Med.20199433634510.1016/j.jtcme.2018.03.00131453130
     [Google Scholar]
  107. Ebrahimi-MamaghaniM. Saghafi-AslM. PirouzpanahS. Asghari-JafarabadiM. Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome: A randomized controlled clinical trial.J. Obstet. Gynaecol. Res.20144041067107610.1111/jog.1231124612081
     [Google Scholar]
  108. ShahinA.Y. MohammedS.A. Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates – a randomized trial.Gynecol. Endocrinol.201430750551010.3109/09513590.2014.89598324592984
     [Google Scholar]
  109. WangJ.G. AndersonR.A. GrahamG.M.III ChuM.C. SauerM.V. GuarnacciaM.M. LoboR.A. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: A pilot study.Fertil. Steril.200788124024310.1016/j.fertnstert.2006.11.08217296187
     [Google Scholar]
  110. ForouhariS. The effect of soya on some hormone levels in women with polycystic ovary syndrome (balance diet): A cross over randomized clinical trial.Bull Env Pharmacol Life Sci201331246250
     [Google Scholar]
  111. ChenJ.T. TominagaK. SatoY. AnzaiH. MatsuokaR. Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: A possible monotherapy and a combination therapy after failure with first-line clomiphene citrate.J. Altern. Complement. Med.201016121295129910.1089/acm.2009.069621034160
     [Google Scholar]
  112. FarzanaF. Effects of flax seeds supplementation in polycystic ovarian syndrome.Int. J. Pharm. Sci. Rev. Res.2015311113119
     [Google Scholar]
  113. GrantP. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. a randomized controlled trial.Phytother. Res.201024218618810.1002/ptr.290019585478
     [Google Scholar]
  114. NaeimiS.A. Assessing the effect of processed nigella sativa on oligomenorrhea and amenorrhea in patients with polycystic ovarian syndrome: A pilot study.Int. J. Pharm. Sci. Res.201891147164722
     [Google Scholar]
  115. Haj-HuseinI. TukanS. AlkazalehF. The effect of marjoram (O riganum majorana ) tea on the hormonal profile of women with polycystic ovary syndrome: A randomised controlled pilot study.J. Hum. Nutr. Diet.201629110511110.1111/jhn.1229025662759
     [Google Scholar]
  116. Hassanzadeh BashtianM. EmamiS.A. MousavifarN. EsmailyH.A. MahmoudiM. Mohammad PoorA.H. Evaluation of fenugreek (Trigonella foenum-graceum L.), effects seeds extract on insulin resistance in women with polycystic ovarian syndrome. Iranian journal of pharmaceutical research.Iran. J. Pharm. Res.201312247548124250624
     [Google Scholar]
  117. WardleJ.L. AdamsJ. LuiC.W. A qualitative study of naturopathy in rural practice: A focus upon naturopaths’ experiences and perceptions of rural patients and demands for their services.BMC Health Serv. Res.201010118510.1186/1472‑6963‑10‑18520584288
     [Google Scholar]
  118. SteelA. WardleJ. DiezelH. JohnstoneK. AdamsJ. Educating for collaboration: The outcomes of an interprofessional education workshop for complementary and alternative maternity care providers.Adv. Integr. Med.201411172410.1016/j.aimed.2013.05.001
     [Google Scholar]
  119. GopalM. DuntleyS. UhlesM. AttarianH. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome.Sleep Med.20023540140410.1016/S1389‑9457(02)00033‑314592171
     [Google Scholar]
/content/journals/cis/10.2174/012210299X272638240213105938
Loading
Exploring the Contribution of Traditional Medicinal Herbs in Managing Polycystic Ovary Syndrome: A Comprehensive Review
Curr. Indian Sci. 2, e2210299X272638 (2024); https://doi.org/10.2174/012210299X272638240213105938
/content/journals/cis/10.2174/012210299X272638240213105938
/content/journals/cis/10.2174/012210299X272638240213105938
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Infertility; Insulin; Medicinal herbs; Obesity; PCOS; Sex hormones

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test